Bezlotoxumab Efficacy and Tolerability in Cancer Patient
NCT04415918
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
132
Enrollment
OTHER
Sponsor class
Conditions
Clostridium Difficile Infection Recurrence
Interventions
DRUG:
Bezlotoxumab Injection
Sponsor
The Cooper Health System